Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Gross Margin (2025 - 2026)

Updated

Crinetics Pharmaceuticals (CRNX) reported Gross Margin of 99.39% for Q2 2026, down 0.61 percentage points from 100.00% a year earlier but up 1.25 percentage points from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Gross Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Crinetics Pharmaceuticals' Gross Margin came in at 87.51%; for FY2025, it was 86.02%, down 13.98 percentage points from FY2024.

  • By year, Gross Margin came in at 100.00% in FY2024 (unchanged) and 100.00% in FY2023.
  • Five-year quarterly Gross Margin spans a low of 98.14% in Q1 2026 and a high of 100.00% in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn 99.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 99.39%
Mar 31, 2026 98.14%
Jun 30, 2025 100.00%
Mar 31, 2025 100.00%
API Access

Crinetics Pharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CRNX&period=max&api_key=YOUR_API_KEY